By NewsDesk @infectiousdiseasenews
Since our last report on June 30, four additional Ebola Virus Disease (EVD) cases and one death has been reported in the outbreak in the Democratic Republic of the Congo’s (DRC’s) Equateur province.
On July 1, three new cases were reported and yesterday, one additional case was reported, bringing the outbreak total to 34 since it began on June 1.
In related news, the European Commission adopted the decision granting marketing authorisations to the company Janssen, a Johnson & Johnson company, for a vaccine against Ebola Wednesday.
The new Ebola vaccine, which consists of two components, called Zabdeno and Mvabea, had been in development with the support of the Commission. This decision follows a recommendation from the European Medicines Agency (EMA), which has assessed the benefits and risks of the vaccine.
Stella Kyriakides, Commissioner in charge of Health and Food Safety, said: “This is the second Ebola vaccine that the Commission authorises in less than a year and confirms once again that the EU remains at the forefront of the global effort to save lives from this virus. We know very well from the coronavirus crisis that viruses do not respect borders – protecting the health of others protects the health of all.”
- Afghanistan reports 7 additional wild poliovirus cases in past week
- SARS-CoV-2: Variation in the viral genome makes it a more infectious strain, does not seem to cause more severe disease
- Anaplasmosis research: Bacteria tinkers with tick’s gene expression to spread to new hosts
- Plague case reported in Mongolia, Linked to eating marmot
- Philippines reports additional 1,000 COVID-19 cases, Behavior change encouraged
- Brazil COVID-19 cases top 1.4 million, Yanomami villages get help